One of the diabetes market’s newest spinoffs is set to undergo a significant change. Embecta, which was spun out of Becton Dickinson in April of 2022, is instituting a restructuring plan that includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results